Mergers & Acquisitions Mergers & Acquisitions

AbbVie-Allergan deal approved in South Korea

By Choi Hyung-jo
  • 12 Jan 2020 20:27
  • 12 Jan 2020 20:27
US biopharmaceuticals supplier AbbVie's proposed acquisition of Dublin-based Allergan has been approved by South Korea's antitrust agency, MLex has learned.

It is understood that the Korea Fair Trade Commission, or KFTC, cleared the deal without conditions.

The merger was reviewed through the regulator's "fast-track" review procedure, which means the agency didn't

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News